Page 67 - AN-3-1

Advanced Neurology Dementia with Lewy bodies and substance misuse

doi: 10.1007/s10863-014-9540-5 87. Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, et al.
Plasma membrane ion permeability induced by mutant
76. Pacheco C, Aguayo LG, Opazo C. An extracellular
mechanism that can explain the neurotoxic effects alpha-synuclein contributes to the degeneration of neural
of α-synuclein aggregates in the brain. Front Physiol. cells. J Neurochem. 2006;97(4):1071-1077.
2012;3:297. doi: 10.1111/j.1471-4159.2006.03803.x
doi: 10.3389/fphys.2012.00297 88. Selkoe DJ. Biochemistry and molecular bilology of amylod
77. Milanese C, Cerri S, Ulusoy A, et al. Activation of the DNA B-protein and the mechanism of Alzheimer’s disease. Handb
damage response in vivo in synucleinopathy models of Clin Neurol. 2008;89:245-260.
Parkinson’s disease. Cell Death Dis. 2018;9:818. doi: 10.1016/S0072-9752(07)01223-7
doi: 10.1038/s41419-018-0848-7 89. Uchicara T, Tsuchiya K. Neuropathology of pick body
78. Danzer KM, Haasen D, Karow AR, et al. Different species disease. Handb Clin Neurol. 2008;89:415-430.
of alpha-synuclein oligomers induce calcium influx and doi: 10.1016/S0072-9752(07)01238-9
seeding. J Neurosci. 2007;27(34):9220-9232.
90. Saxton J, Morrow L. Toxic dementias. Handb Clin Neurol.
doi: 10.1523/JNEUROSCI.2617-07.2007 2008;89:851-862.
79. Virdi GS, Choi ML, Evans JR, et al. Protein aggregation and doi: 10.1016/S0072-9752(07)01274-2
calcium dysregulation are hallmarks of familial Parkinson’s
disease in midbrain dopaminergic neurons. NPJ Parkinsons 91. Pétursson H. The benzodiazepine withdrawal syndrome.
Dis. 2022;8:162. Addiction. 1994;89(11):1455-1459.
doi: 10.1038/s41531-022-00423-7 doi: 10.1111/j.1360-0443.1994.tb03743.x
80. Ke PC, Zhou R, Serpell LC, et al. Half a century of amyloids: 92. Stewart S. The effects of benzodiazepines on cognition.
Past, present and future. Chem Soc Rev. 2020;49(15):5473-5509. J Clin Psychiatry. 2005;66 Suppl 2:9-13.
doi: 10.1039/c9cs00199a 93. Zetsen SPG, Schellekens AFA, Paling EP, Kan CC,
Kessels RPC. Cognitive functioning in long-term
81. Tanaka M, Toldi J, Vécsei L. Exploring the etiological links benzodiazepine users. Eur Addict Res. 2022;28(5):377-381.
behind neurodegenerative diseases: Inflammatory cytokines
and bioactive kynurenines. Int J Mol Sci. 2020;21:2431. doi: 10.1159/000525988
doi: 10.3390/ijms21072431 94. Morin L, Johnell K, Laroche M, Fastbom J, Wastesson JW. The
epidemiology of polypharmacy in older adults: register-based
82. Sastre M, Klockgether T, Heneka MT. Contribution of
inflammatory processes to Alzheimer’s disease: Molecular prospective cohort study. Clin Epidemiol. 2018;10:289-298.
mechanisms. Int J Dev Neurosci. 2006;24(2-3):167-176. doi: 10.2147/CLEP.S153458
doi: 10.1016/j.ijdevneu.2005.11.014 95. Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.
83. Shahidehpour RK, Higdon RE, Crawford NG, et al. Coadministration of nefazodone and benzodiazepines: III.
Dystrophic microglia are associated with neurodegenerative A pharmacokinetic interaction study with alprazolam. J Clin
disease and not healthy aging in the human brain. Neurobiol Psychopharmacol. 1995;15(6):399-408.
Aging. 2021;99:19-27. doi: 10.1097/00004714-199512000-00003
doi: 10.1016/j.neurobiolaging.2020.12.003 96. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome.
84. Streit WJ, Xue QS. Microglia in dementia with Lewy bodies. Ochsner J. 2013;13(4):533-540.
Brain Behav Immun. 2016;55:191-201. 97. Rivasi G, Rafanelli M, Mossello E, Brignole M, Ungar A.
doi: 10.1016/j.bbi.2015.10.012 Drug-related orthostatic hypotension: Beyond anti-
hypertensive medications. Drugs Aging. 2020;37:725-738.
85. Simon C, Soga T, Ahemad N, Bhuvanendran S, Parhar I.
Kisspeptin-10 rescues cholinergic differentiated SHSY-5Y doi: 10.1007/s40266-020-00796-5
cells from α-synuclein-induced toxicity in vitro. Int J Mol 98. Doraiswamy PM, Husain MM. Anticholinergic drugs and
Sci. 2022;23(9):5193. elderly people: A no brainer? Lancet Neurol. 2006;5(3):379-380.
doi: 10.3390/ijms23095193 doi: 10.1016/S1474-4422(06)70421-5
86. Cremades N, Cohen SI, Deas E, et al. Direct observation 99. National Center for Drug Abuse Statistics. Prescription Drug
of the interconversion of normal and toxic forms of Abuse Statistics. Available from: https://drugabusestatistics.
α-synuclein. Cell. 2012;149(5):1048-1059.
org/prescription-drug-abuse-statistics [Last accessed on
doi: 10.1016/j.cell.2012.03.037 2023 Oct 19].

Volume 3 Issue 1 (2024) 15 https://doi.org/10.36922/an.2232